CTIS2023-504519-34-01招募中1 期
sing live vaccines to induce beneficial innate immune training and reduce systemic inflammation in COPD patients (COPD-LIVE)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+(—)
- 性别
- All
入选标准
- •Must have specialist verified, spirometry-confirmed, COPD., Age > 40 years, Able to give informed consent
排除标准
- •Acute febrile ilness, Oral or intravenous corticosteroid at a dose =10 mg/day over 3 months, Cardiac arythmia, Blood dyscrasia, Known allergy to either the BCG or MMR vaccines or severe adverse effects during prior vaccination., Allergy to MMR vaccine components, neomycin or egg proteins., Known prior, active or latent infection with mycobacterium tuberculosis., Pregnancy or breastfeeding, Vaccination with a live vaccine within 4 weeks, Severe immunocompromisation (HIV-1 infection, organ- or bone marrow transplantation, chemotherapy, primary immune defect, anti-cytokine therapy, immunosuppressant treatment)., Active solid or non-solid malignancy or lymphona within 2 years, excluding basal cell carcinoma
研究者
相似试验
已完成
4 期
Live Vaccines and Innate Immune Training in COPD.Trained Innate ImmunityCOPDNCT06257212Josefin Eklöf60
已完成
不适用
Training of innate immunity by vaccination with γ-irradiated BCGImmune modulationmodulation of the immune system10002252NL-OMON38603niversitair Medisch Centrum Sint Radboud15
进行中(未招募)
1 期
Strengthening the protection against influenza in the elderlyImmune response to seasonal influenza vaccineMedDRA version: 20.0Level: HLTClassification code 10022005Term: Influenza viral infectionsSystem Organ Class: 100000004862MedDRA version: 21.0Level: LLTClassification code 10060063Term: Influenza serologySystem Organ Class: 100000004848EUCTR2019-002781-12-DKniversity of Southern Denmark, Bandim Health Project300
已完成
1 期
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial NeoplasiaPrecancerous ConditionCervical CancerNCT00121173Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins16
已完成
1 期
VNP20009 in Treating Patients With Advanced Solid TumorsUnspecified Adult Solid Tumor, Protocol SpecificNCT00006254Vion Pharmaceuticals
